LONDON, June 30, 2020 /PRNewswire/ -- Medicinal cannabis
continues to get traction in the UK, with the launch by Sapphire
Clinics of reduced appointment costs for patients contributing to
the UK's real-world evidence base. This is a welcome initiative to
increase the number of patients who can get access to medicinal
cannabis. Ananda continues to work towards gaining its licence
to grow medicinal cannabis in the UK.
If you would like further information on Ananda's initiatives
and progress please contact Melissa
Sturgess, Ananda's CEO, on ms@anandadevelopments.com.
https://www.sapphireclinics.com/sapphire-access-scheme/?mc_cid=ca603d81ea
The Directors of the Company accept responsibility for the
contents of this announcement.
ANANDA DEVELOPMENTS PLC
Chief Executive Officer
Melissa
Sturgess
+44 (0)7717-573-235
ir@anandadevelopments.com
Investor Relations
Jeremy Sturgess-Smith
PETERHOUSE CAPITAL LIMTED
Corporate Finance
Mark
Anwyl
Allie Feuerlein
+44 (0)20-7469-0930
Corporate Broking
Lucy Williams
Duncan Vasey
CELICOURT COMMUNICATIONS
Mark Antelme
Ollie Mills
+44 (0)20-7520-9266
View original
content:http://www.prnewswire.com/news-releases/the-uk-medicinal-cannabis-market-continues-to-grow-notes-ananda-developments-301085754.html
SOURCE Ananda Developments Plc